1.Frontiers in pharmacologyDisruption of PD-1 Enhanced the Anti-tumor Activity of Chimeric Antigen Receptor T Cells Against Hepatocellular Carcinoma."11-4714 was used in Immunocytochemistry to indicate the enhanced anti-tumor efficacy of PD-1-deficient chimeric antigen receptor T cells against hepatocellular carcinoma."AuthorsGuo X,Jiang H,Shi B,Zhou M,Zhang H,Shi Z,Du G,Luo H,Wu X,Wang Y,Sun R,Li Z2.Frontiers in pharmacologyDisruption of PD-1 Enhanced the Anti-tumor Activity of Chimeric Antigen Receptor T Cells Against Hepatocellular Carcinoma."11-4714 was used in Immunocytochemistry to indicate the enhanced anti-tumor efficacy of PD-1-deficient chimeric antigen receptor T cells against hepatocellular carcinoma."AuthorsGuo X,Jiang H,Shi B,Zhou M,Zhang H,Shi Z,Du G,Luo H,Wu X,Wang Y,Sun R,Li Z3.Iranian journal of reproductive medicineComparison of differentiation potential of male mouse adipose tissue and bone marrow derived-mesenchymal stem cells into germ cells."11-4714 was used in Immunofluorescence to investigate appropriate sources beyond embryonic stem cells to obtain germ cells and to compare the differential potentials of these cells."AuthorsHosseinzadeh Shirzeily M,Pasbakhsh P,Amidi F,Mehrannia K,Sobhani A4.Frontiers in immunologyTGF-β Affects the Differentiation of Human GM-CSF+CD4+T Cells in an Activation- and Sodium-Dependent Manner."11-4714 was used in Flow cytometry/Cell sorting to study the environmental cues that promote differentiation of granulocyte-macrophage colony-stimulating factor producing T cells."AuthorsÉliás S,Schmidt A,Kannan V,Andersson J,Tegnér J5.Translational oncologyTumor-Penetrating Peptide Enhances Antitumor Effects of IL-24 Against Prostate Cancer."11-4714 was used in Flow cytometry/Cell sorting to show that interleukin-24 (IL-24)-iRGD induced apoposis and inhibited the growth of PC-3 cells to a significantly greater extent when compared with IL-24 treatment alone."AuthorsYang J,Yin H,Yang J,Wei Y,Fang L,Chai D,Zhang Q,Zheng J |